The Journal of Immunology, Vol 147, Issue 7 2240-2247, Copyright © 1991 by American Association of Immunologists

ARTICLES

Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor

KA Norris, B Bradt, NR Cooper and M So
Department of Molecular Genetics and Biochemistry, University of Pittsburgh, PA 15261.

Evasion of the complement system by microorganisms is an essential event in the establishment of infection. In the case of Trypanosoma cruzi, the causative agent of Chagas disease, resistance to complement- mediated lysis is a developmentally regulated characteristic. Infectious trypomastigotes are resistant to complement-mediated lysis in the absence of immune antibodies, whereas the insect forms (epimastigotes) are sensitive to lysis via the alternative complement pathway. We have purified a developmentally regulated, trypomastigote glycoprotein, gp160, and shown that it has complement regulatory activity. The T. cruzi gp160 restricts complement activation by binding the complement component C3b and inhibiting C3 convertase formation. The protein is anchored in the parasite membrane via a glycosyl phosphatidylinositol linkage, similar to the human complement regulatory protein, decay-accelerating factor. Using anti-gp160 antibodies we have isolated a bacteriophage lgt11 clone expressing a portion of the gp160 gene that shares significant DNA sequence homology with the human DAF gene. These results provide functional, biochemical, and genetic evidence that the T. cruzi gp160 is a member of the C3/C4 binding family of complement regulatory proteins, and that gp160 may provide the infectious trypomastigotes with a means of evading the destructive effects of complement.

This article has been cited by other articles:

				M. Beucher and K. A. Norris Sequence Diversity of the Trypanosoma cruzi Complement Regulatory Protein Family Infect. Immun., February 1, 2008; 76(2): 750 - 758. [Abstract] [Full Text] [PDF]

				J. M. Inal, K.-M. Hui, S. Miot, S. Lange, M. I. Ramirez, B. Schneider, G. Krueger, and J.-A. Schifferli Complement C2 Receptor Inhibitor Trispanning: A Novel Human Complement Inhibitory Receptor J. Immunol., January 1, 2005; 174(1): 356 - 366. [Abstract] [Full Text] [PDF]

				L. Y. L. Lee, X. Liang, M. Hook, and E. L. Brown Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb) J. Biol. Chem., December 3, 2004; 279(49): 50710 - 50716. [Abstract] [Full Text] [PDF]

				W. S. F. Meira, L. M. C. Galvao, E. D. Gontijo, G. L. L. Machado-Coelho, K. A. Norris, and E. Chiari Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients J. Clin. Microbiol., February 1, 2004; 42(2): 707 - 712. [Abstract] [Full Text] [PDF]

				B Fernie-King, D J Seilly, A Davies, and P J Lachmann Subversion of the innate immune response by micro-organisms Ann Rheum Dis, November 1, 2002; 61(90002): ii8 - 12. [Full Text] [PDF]

				W. S. F. Meira, L. M. C. Galvao, E. D. Gontijo, G. L. L. Machado-Coelho, K. A. Norris, and E. Chiari Trypanosoma cruzi Recombinant Complement Regulatory Protein: a Novel Antigen for Use in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Chagas' Disease J. Clin. Microbiol., October 1, 2002; 40(10): 3735 - 3740. [Abstract] [Full Text] [PDF]

				J. M. Inal and J. A. Schifferli Complement C2 Receptor Inhibitor Trispanning and the {beta}-Chain of C4 Share a Binding Site for Complement C2 J. Immunol., May 15, 2002; 168(10): 5213 - 5221. [Abstract] [Full Text] [PDF]

				P. Sepulveda, M. Hontebeyrie, P. Liegeard, A. Mascilli, and K. A. Norris DNA-Based Immunization with Trypanosoma cruzi Complement Regulatory Protein Elicits Complement Lytic Antibodies and Confers Protection against Trypanosoma cruzi Infection Infect. Immun., September 1, 2000; 68(9): 4986 - 4991. [Abstract] [Full Text] [PDF]

				K. A. Norris Stable Transfection of Trypanosoma cruzi Epimastigotes with the Trypomastigote-Specific Complement Regulatory Protein cDNA Confers Complement Resistance Infect. Immun., June 1, 1998; 66(6): 2460 - 2465. [Abstract] [Full Text] [PDF]